Skip to main content
. 2021 Jan 19;10(1):92. doi: 10.3390/antibiotics10010092
ACE2 angiotensin converting enzyme 2
AChE acetylcholinesterase
AD Alzheimer’s disease
ADP adenosine-5′-diphosphate
CB1 cannabinoid receptor 1
CB2 cannabinoid receptor 2
CL clearance
CNS Central Nervous System
COVID-19 Coronavirus disease 2019
CXCR2 CXC chemokine receptor 2
DENV dengue virus
ECAT electrolytic-mediated carotid arterial thrombosis
ENR enoyl-acyl-carrier protein reductase
FLIPR fluorescent imaging plate reader
FST forced swim test
HD Huntington’s disease
HFF human foreskin fibroblast
IGF-1R insulin like growth factor I receptor
IL-6 interleukin-6
IP interstitial pneumonia
K B binding affinity
LPS lipopolysaccharide
MenG demethylmenaquinone methyltranferase
MERS Swine flu
Ebola Middle East respiratory syndrome
MES maximal electroshock
MIC minimum inhibitory concentration
MMV Medicines for Malaria Venture
MRSA methicillin-resistant S. aureus
MSSA methicillin-sensitive S. aureus
NTDs neglected tropical diseases
NTS newly transformed schistosomula
PGR plant growth regulator
PA platelet aggregation
PD Parkinson’s disease
PZQ praziquantel
SARS severe acute respiratory syndrome
SARS-CoV respiratory syndrome coronavirus
SARS-CoV-2 respiratory syndrome coronavirus 2
scPTZ subcutaneous pentylenetetrazole
sEH soluble epoxide hydrolase
Sps bacterial signal peptidase I enzyme
TB tuberculosis
TCC triclocarban
TRPV1 transient receptor potential vanilloid 1
TST tail suspension test
Vdss volume of distribution
VLA-4 very late antigen-4
VRSA vancomycin-resistant S. aureus
WNV West Nile virus
YFV Yellow fever virus
ZIKV Zika virus virus